ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Champalimaud Foundation at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Champalimaud Foundation takes part in 3 sessions at ESMO 2026 in Madrid. Its work centres on breast cancer prevention and reducing treatment intensity. It examines pertuzumab use in early breast cancer with no lymph-node involvement.

OrganizationESMO 2026 Attendance
Champalimaud Foundation
Lisbon, Portugal
Cancer centre & hospital
Private biomedical research foundation in Lisbon, Portugal, whose clinical centre treats cancer patients.
Talk
Sun Oct 25
17:20–17:45
Breast cancer drug prevention in 2026
Pillars of personalised cancer prevention: The breast cancer case
Breast cancer
Chair
Mon Oct 26
10:15–11:45
Rapid oral 2: Basic science and translational research
with Hospital Clínico Universitario de Valencia, Peter MacCallum Cancer Centre
Biomarkers & precision oncology
Abstract
Mon Oct 26
10:30–10:42
Invited Discussant 4249RO, 4250RO and 4251RO
Rapid oral 2: Basic science and translational research
Biomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Champalimaud Foundation

Tell us what you sell and we’ll find the people at Champalimaud Foundation most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction